Arkolith/Insider Trading/PHIO/Form 4

Bitterman Robert J

President & CEO, DirectorPhio Pharmaceuticals Corp. (PHIO) · full profile →Form 4 · filed Jul 5, 2023
Net Buying
Open-Market Buys
$6K
Open-Market Sells
$0
Net Open-Market Flow
$6K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2023Buy(P)1K$2.84$3K19K
Jun 30, 2023Buy(P)1K$2.88$3K18K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-041254) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML